Home » Posts tagged 'malcolm stacey' (Page 2)
Tag Archives: malcolm stacey
SHARE ATTACK – 80 great tips to survive and thrive as a trader.
80 Great Tips to survive and thrive as a Trader
Published by Harriman House, Share Attack is the latest book from share author and former BBC journalist Malcolm Stacey.
Simply click on the cover image to go to the Harriman House website for more info.
Our readers can take advantage of a unique offer from us. Order Share Attack and enter the following codes to receive 25% discount from RRP.
SHAREATTACK25PB – for the paperback here
SHAREATTACK25EB – for the eBook
Malcolm Stacey of ShareProphets – My First-Hand Check on Medical Opportunities As I End Up in Hospital. Ref. Feedback, Avacta & Advanced Oncotherapy
Hello Share Folk. I’m going to the hospital today to see about my prostate gland. I started the routine tests a few years ago and have been under the eye of a brilliant consultant ever since. There’s a lot of debate of whether we should have these tests done, as it causes a lot of anxiety and their reliability is not always that great. On the whole I would suggest you do have them done, if you’re of a certain age. But what do I know?
The visit to hospital confirms my view, though, that there one thing more important than the health of our shares – and that’s the health of us.
Your shares can drop like a lead-studded anvil down a coal shaft, but if we have good health, collapsing stocks are, in comparison, not in the least bit disturbing.
You can combine the two concerns of course by buying shares in companies, which push forward the frontiers of medical science. You may recall that I’ve invested big time in three life science firms – Feedback (FDBK) Avacta (AVCT) and Advanced Oncotherapy (AVO).
Now at first all three stocks shot ahead. But in recent months there has been a bit of decay going on.
This is not unexpected. Whenever you get a penny share, which looks really promising, there is an army of chancers out there who will take a punt just because the stock is rising like a discarded champagne cork from a submarine.
But when the momentum – usually set off by a single piece of good news for the company – winds down, the same army of opportunists sell again. This dumping continues until the next piece of good news.
In the case of all three aforementioned shares, the future outlook is no less rosier than when I first bout their prospects to your attention.
So I expect good news to keep spewing forth as the months, and indeed years, roll by. Then the army of chancers will turn up again and the share prices will hit mew highs once more. (Though I cannot be certain).
But I’m an optimist, as you know, so you must make up your own mind.
See you in the Punter’s Return tonight?
– See more at: http://www.shareprophets.com/views/16395/my-first-hand-check-on-medical-opportunities-as-i-end-up-in-hospital-ref-feedback-avacter-advanced-oncatherapy#sthash.ZYla6RsZ.dpuf
Malcolm Stacey of ShareProphets – Feedback PLC, Don’t You Hate the Small Profit-Takers?
Hello Share Bunnies. There was some interesting share movements after all the good news came out for Feedback (FDBK), the minnow capitalised at a mere £5 million.
– See more at: http://www.shareprophets.com/views/15556/don-t-you-hate-the-small-profit-takers-ref-feedback#sthash.oBmJQaPC.dpuf
Malcolm Stacey of ShareProphets – Feedback and the Big Spanish Connection
Hello Share Thrashers. It’s not my custom to return to promising shares I’ve brought to your attention in the recent past. I normally wait at least six months or so – with only a few exceptions.– See more at: http://www.shareprophets.com/views/15537/feedback-and-the-big-spanish-connection#sthash.d1mviXV7.dpuf
Special offer to our readers – 25% off RRP on Malcolm Stacey’s Share Attack!
80 Great Tips to survive and thrive as a Trader
Published by Harriman House, Share Attack is the latest book from share author and former BBC journalist Malcolm Stacey.
Simply click on the cover image to go to the Harriman House website for more info.
Our readers can take advantage of a unique offer from us. Order Share Attack and enter the following codes to receive 25% discount from RRP.
SHAREATTACK25PB – for the paperback here
SHAREATTACK25EB – for the eBook
Special offer to our readers – 25% discount on RRP on Share Attack
80 Great Tips to survive and thrive as a Trader
Published by Harriman House, Share Attack is the latest book from share author and former BBC journalist Malcolm Stacey.
Simply click on the cover image to go to the Harriman House website for more info.
Our readers can take advantage of a unique offer from us. Order Share Attack and enter the following codes to receive 25% discount from RRP.
SHAREATTACK25PB – for the paperback here
SHAREATTACK25EB – for the eBook here
ShareProphets – Feedback Shares Soften, but is that a Buying Opportunity?
By Malcom Stacey at ShareProphets
Hello Share Sappers. I beg your indulgence to return to Feedback (FDBK), the company which uses whizzo computers to help diagnose and monitor many types of cancer. As reported previously, this could be a topping investment. Though, as per usual, we should always add a cautionary note about medical pioneers.
This is because they can always be taken over by some even more revolutionary gizmo or they might not get every licence they hope for.
There is also the worry that the NHS, to name just one medical services giant, is short of money these days as the number of patients grow, fuelled by longevity.
Having said that, I want to go over a few reasons why I’m so enthusiastic about Feedback.
One, it is a small company, capitalised at just £5million and has a comparatively small number of shares out there.
A heck of a lot of these shares are owned by directors, families and friends.
This means there are even fewer shares in the market place. And we all know the effects of limited supply and demand.
Also the very fact that the big cheeses of Feedback have so much skin in the game is very re-assuring.
As usual with this sort of pioneering company, a bit of good news – like a tasty new contract – will send the shares skywards. And, after a fallow time, good news could be about due.
The shares reached a high not so long ago at 3.2 pence. It’s softened to 2.8p since then, as profit takers have succumbed to temptation. But nothing has happened to justify the slight fall, and if you read the company’s bumph and believe it, there should be some jolly profit to come.
Click here for full ShareProphets article.
Shareprophets – How Advanced Oncotherapy Might Rise – Now a £20m Placing of New Shares Is Spoken For.
By Malcolm Stacey | Tuesday 5 May 2015
Disclosure: I own shares in one or more of the stocks mentioned. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.
Hello Share Trimmers. Investors in Advanced Oncotherapy (AVO) are in a peculiar situation. For though our shares are now trading at just a touch over 8p, they could be worth a lot more.
The share price has been held down by a huge placing of extra shares. These shares were lapped up by institutions and existing big shareholders.
We‘re told that this placing was over-subscribed. This suggests to me that the participants could have even paid a bit more for the new stock.
Two or three weeks ago, Advanced was on a massive roll. The stock rose to around 16p a shares from about 3p, just a few months before that.
So shareholders, myself included, were sitting on a huge profit at 16p. We should have cashed in then, as shares started to decay, helped by the company’s announcement that a placing was to take place.
It’s a wonderful thing hindsight, and I kick myself that instead of selling shares at the 15p point, I actually bought more. so my paper profits so far are not that great.
So what happens now? Well, the placing raised a massive £20 million. A large chunk will be used to build its exciting new machines for zapping cancer cells with proton beams.
That extra cash should be applauded by all shareholders as it means the project is now well on course. Perhaps it will stun the medical world, though I understand there is a little competition somewhere out there.
Now it has this money in the bag, Advanced’s future looks tempting to this medical layman. I do know that some very big cheeses in the cancer world are involved in this venture, some of them holding large numbers of shares.
The share is now little more than 8p, but I can now see acceleration, now that the placing is out of the way.
It’s a popular view, anyway, in the Punter’s Return. More here
Malcolm Stacey has been writing about shares for more than 20 years. His first book “The Armchair Tycoon” was first published in 1998 but a revised 2014 e-version is now available. To obtain a FREE copy fill in the form HERE